Latest news

• UK trial of fourth vaccine dose shows increased protection against COVID-19

  According to findings from a UK trial, COV-BOOST, fourth doses of COVID-19 vaccines have shown an increase in protection against the virus, especially in those over the age of ... will take into consideration whether new sub-variants are spreading, and

• COVID-19 booster to be made available to those over 75 and high risk adults and children

  Professor Wei Shen Lim, chair of COVID vaccination at the JCVI, said: "Last year's booster vaccination programme has so far provided excellent protection against severe COVID-19. ... Data has suggested that older people who have had two doses of a

• MHRA issues CMA for Novavax COVID-19 vaccine

  Nuvaxovid COVID-19 vaccine, which offers up to 89% protection against COVID-19. ... The MHRA has confirmed that it is safe as a first and second dose in people aged 18 years and over, making this the fifth COVID-19 vaccine to be approved

• J&J’s COVID-19 booster shows 85% effectiveness in preventing hospitalisation for COVID-19 in study

  We believe that the protection could be due to the robust T-cell responses induced by the Johnson &Johnson COVID-19 vaccine. ... We are therefore encouraged to see that boosting with the Johnson &Johnson COVID-19 vaccine regimen provides strong

• US COVID-19 booster programme expanded

  The move comes after J&J announced new data 'reinforcing the strong and long-lasting protection of its COVID-19 vaccine' that covers both the original single-shot dose and a ... booster. In the largest real-world evidence study into a COVID-19 vaccine